Table 2.
Rates of hepatitis B markers before and after starting the hepatitis B vaccination program in Iran.
| Variable | Frequency (%) |
p-value | RR and 95% CI of HBV (Vaccinated/Unvaccinated) |
|||
|---|---|---|---|---|---|---|
| Vaccinated | Unvaccinated | Total | ||||
| HBSAg | Positive | 7 (0.6) | 16 (1.1) | 23 (0.9) | 0.112 | 0.49 (0.20–1.20) |
| Negative | 1255 (99.4) | 1414 (98.9) | 2669 (99.1) | |||
| Anti-HBc | Positive | 69 (5.5) | 106 (7.4) | 175 (6.5) | 0.041 | 0.74 (0.55–0.98) |
| Negative | 1193 (94.5) | 1324 (92.6) | 2517 (93.5) | |||
| Hepatitis B (HBSAg + or Anti-HBc+) | Yes | 75 (5.9) | 119 (8.3) | 194 (7.2) | 0.017 | 0.71 (0.54–0.94) |
| No | 1187 (94.1) | 1311 (91.7) | 2498 (92.8) | |||